20/20 BIOLABS, INC. Diluted Shares Outstanding (Weighted Average)
20/20 BIOLABS, INC. (AIDX) reported Diluted Shares Outstanding (Weighted Average) of 10.79 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- 20/20 BIOLABS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 10.79M shares, a 123.73% increase year-over-year.
- 20/20 BIOLABS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 7.66M shares, a 58.76% increase year-over-year.
- 20/20 BIOLABS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 4.82M shares.
- 20/20 BIOLABS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 4.82M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|
| 2026-06-30 | 10.79M shares 10-Q · filed 2026-08-14 | 9.23M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 7.66M shares 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | 4.93M shares POS AM · filed 2026-04-06 | ||
| 2025-06-30 | 4.82M shares 10-Q · filed 2026-08-14 | 4.82M shares 10-Q · filed 2026-08-14 | |
| 2025-03-31 | 4.82M shares 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | 4.80M shares POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |